Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects
Condition: Drug Interactions Interventions: Drug: CYP450 Cocktail and Transporter Substrates with Pacritinib; Drug: Part 2 -Group A Bosentan 125 mg (CYP450 3A4 inducer) with Pacritinib; Drug: Part 2 Group B - Fluconazole (CYP450 3A4 inhibitor) with Pacritinib Sponsors: CTI BioPharma; PPD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2022 Category: Research Source Type: clinical trials